Correction to: Journal of Neuro-Oncology https://doi.org/10.1007/s11060-022-03987-9

Possible conflicts of interest were not disclosed in the original publication. Dr. Michael Sughrue is the Chief Medical Officer, co-founder, and shareholder for Omniscient Neurotechnology. Figure 1 and figure 2 were made using software from Omniscient Neurotechnology. The original article has been corrected.